Raymond James cut shares of Omega Therapeutics (NASDAQ:OMGA – Free Report) from an outperform rating to a market perform rating in a report issued on Friday morning, MarketBeat Ratings reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results